NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
This grant funds small businesses engaged in technology transfer and research that can lead to commercialization of innovative health solutions.
About this program
The NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) is designed to support small businesses in the development of innovative technologies that can improve health outcomes. This grant encourages collaboration between small businesses and research institutions to facilitate the commercialization of new health-related technologies. It is particularly aimed at small businesses that are looking to conduct research and development activities that can lead to clinical trials and eventual market entry. Eligible applicants include small businesses that meet the NIH's definition of a small business concern and are engaged in research that has the potential for commercialization. The grant supports various stages of development, from early-stage research to clinical trials, allowing businesses to leverage funding to advance their projects. The program is intended to foster innovation and support the growth of small businesses in the health sector, ultimately benefiting public health through the introduction of new technologies.
Eligibility
Small businesses that meet the NIH's definition of a small business concern and are engaged in health-related research.
Requirements
- Must be a small business
- Collaboration with a research institution is required